WearableDose
InactiveWearableDose improves radiotherapy using an innovative electronic polymer detector that accurately detects, directs, and measures radiation to tumors, reducing costs and significantly enhancing treatment safety and efficacy.
What it does
"WearableDose is a pioneering medtech company focused on enhancing radiotherapy through the use of an innovative electronic polymer detector. This cutting-edge technology accurately detects, directs, and measures radiation to tumors, leading to reduced costs and significantly improved treatment safety and efficacy. By revolutionizing the way radiation is delivered to patients, WearableDose is making strides in improving cancer treatment outcomes and patient care. Their commitment to innovation and patient well-being positions them as a key player in advancing the field of radiotherapy and contributing to the overall improvement of cancer treatment protocols."
Next to it in Healthcare and bio · electronic polymer detector for radiotherapy
- Cerevia NeurosciencesPlug and Play PnP 2026
Cerevia Neurosciences is a full stack closed-loop image-guide network neuromodulation platform that integrates fMRI and AI-driven personalization to treat dementia.
- Edulis TherapeuticsPlug and Play PnP 2026
Founded by an Ex-NASA engineer and two gastroenterologists, Edulis is building the first drug delivery system for sustained, localized treatment of chronic GI diseases like IBD and colorectal cancer.
- ENF MedicalPlug and Play PnP 2026
ENF Medical develops ENgraft, a scalable, bioresorbable bone graft platform—from dental to long-bone defects—designed for surgeons to regenerate bone, improve healing, and reduce repeat surgeries.
- Humimic BiosystemsPlug and Play PnP 2026
Humimic Biosystems provides organ-on-chip models for human-relevant preclinical research and drug testing.
- LevisonicsPlug and Play PnP 2026
Levisonics is developing a drop-of-blood, point-of-care coagulation analyzer that delivers in a single test the comprehensive clotting insights that today require multiple separate lab and point-of-care tests.
- NEXI Biotech IncPlug and Play PnP 2026
NEXI Biotech develops in vitro neurotechnology models for improved neurological drug discovery and translation.
- OncodeaPlug and Play PnP 2026
Oncodea focuses on non-invasive and affordable technology to detect cancers in their early stages.
- Rebio HealthPlug and Play PnP 2026
電気化学殺菌技術により、難治性のバイオフィルム感染症を低侵襲かつ高効率に解決する医療機器を開発